Bazemore Robert B
Insider CIK 1620152 · ARDX Director · AKTX Director · EPZM President & CEO, Director · NTGN Director · NUVB Director · GEVA Chief Operating Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AKTX Akari Therapeutics Plc | M Exercise deriv | 2026-10-14 | 2026-10-16 | 3,093 | $16.16 | $50.0K | 0 | SEC↗ |
| AKTX Akari Therapeutics Plc | M Exercise deriv | 2026-10-14 | 2026-10-16 | 773 | $16.16 | $12.5K | 0 | SEC↗ |
| AKTX Akari Therapeutics Plc | M Exercise | 2026-10-14 | 2026-10-16 | 3,093 | $0.00 | $1 | 22,759 | SEC↗ |
| AKTX Akari Therapeutics Plc | M Exercise | 2026-10-14 | 2026-10-16 | 773 | $0.00 | $0 | 19,666 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award | 2026-10-05 | 2026-10-16 | 4,677 | $7.90 | $36.9K | 18,893 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award deriv | 2026-08-18 | 2026-10-16 | 15,000 | — | $0 | 15,000 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award deriv | 2026-08-18 | 2026-10-16 | 45,000 | — | $0 | 45,000 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award | 2026-08-18 | 2026-10-16 | 13,100 | $7.90 | $103.5K | 14,216 | SEC↗ |
| ARDX ARDELYX, INC. | A Award deriv | 2026-06-16 | 2026-06-18 | 39,715 | — | $0 | 39,715 | SEC↗ |
| ARDX ARDELYX, INC. | A Award | 2026-06-16 | 2026-06-18 | 26,455 | — | $0 | 68,006 | SEC↗ |
| NUVB Nuvation Bio Inc. | A Award deriv | 2026-05-21 | 2026-05-26 | 123,397 | — | $0 | 123,397 | SEC↗ |
| AKTX Akari Therapeutics Plc | P Buy deriv | 2025-12-16 | 2025-12-18 | 123,731 | — | $0 | 123,731 | SEC↗ |
| AKTX Akari Therapeutics Plc | P Buy deriv | 2025-12-16 | 2025-12-18 | 123,731 | $0.40 | $49.5K | 123,731 | SEC↗ |
| AKTX Akari Therapeutics Plc | P Buy deriv | 2025-12-16 | 2025-12-18 | 30,932 | — | $0 | 30,932 | SEC↗ |
| AKTX Akari Therapeutics Plc | P Buy deriv | 2025-12-16 | 2025-12-18 | 30,932 | $0.40 | $12.4K | 30,932 | SEC↗ |
| ARDX ARDELYX, INC. | A Award deriv | 2025-06-18 | 2025-06-23 | 54,059 | — | $0 | 54,059 | SEC↗ |
| ARDX ARDELYX, INC. | A Award | 2025-06-18 | 2025-06-23 | 41,551 | — | $0 | 41,551 | SEC↗ |
| NUVB Nuvation Bio Inc. | A Award deriv | 2025-05-21 | 2025-05-23 | 292,983 | — | $0 | 292,983 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award deriv | 2025-03-20 | 2025-03-24 | 175,000 | — | $0 | 175,000 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award deriv | 2025-03-20 | 2025-03-24 | 225,000 | — | $0 | 225,000 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award deriv | 2025-03-06 | 2025-03-10 | 44,642 | $1.12 | $50.0K | 44,642 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award deriv | 2025-03-06 | 2025-03-10 | 44,642 | $1.12 | $50.0K | 44,642 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award | 2025-03-06 | 2025-03-10 | 44,642 | $1.12 | $50.0K | 44,642 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award deriv | 2024-09-17 | 2024-09-18 | 5,000,000 | — | $0 | 5,000,000 | SEC↗ |
| NUVB Nuvation Bio Inc. | A Award deriv | 2024-09-03 | 2024-09-05 | 200,801 | — | $0 | 200,801 | SEC↗ |
| ARDX ARDELYX, INC. | A Award deriv | 2024-06-14 | 2024-06-17 | 40,243 | — | $0 | 40,243 | SEC↗ |
| ARDX ARDELYX, INC. | A Award deriv | 2023-06-15 | 2023-06-16 | 49,237 | — | $0 | 49,237 | SEC↗ |
| NUVB Nuvation Bio Inc. | A Award deriv | 2023-05-15 | 2023-05-17 | 366,744 | — | $0 | 366,744 | SEC↗ |
| ARDX ARDELYX, INC. | A Award deriv | 2022-06-15 | 2022-06-17 | 100,000 | — | $0 | 100,000 | SEC↗ |
| NUVB Nuvation Bio Inc. | A Award deriv | 2022-05-16 | 2022-05-18 | 118,784 | — | $0 | 118,784 | SEC↗ |
| NUVB Nuvation Bio Inc. | A Award deriv | 2022-05-16 | 2022-06-28 | 140,713 | — | $0 | 140,713 | SEC↗ |
| NUVB Nuvation Bio Inc. | A Award deriv | 2021-10-29 | 2021-11-02 | 45,229 | — | $0 | 45,229 | SEC↗ |
| ARDX ARDELYX, INC. | A Award deriv | 2021-06-16 | 2021-06-21 | 32,765 | — | $0 | 32,765 | SEC↗ |
| NUVB Nuvation Bio Inc. | P Buy | 2021-03-30 | 2021-04-01 | 5,000 | $9.98 | $49.9K | 5,000 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2021-03-25 | 2021-03-29 | 10,328 | $7.85 | $81.1K | 322,626 | SEC↗ |
| NUVB Nuvation Bio Inc. | A Award deriv | 2021-02-10 | 2021-02-12 | 187,658 | — | $0 | 187,658 | SEC↗ |
| NUVB Nuvation Bio Inc. | A Award deriv | 2021-02-10 | 2021-02-12 | 51,703 | — | $0 | 51,703 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2021-02-04 | 2021-02-05 | 3,890 | $11.21 | $43.6K | 331,977 | SEC↗ |
| EPZM Epizyme, Inc. | A Award deriv | 2021-02-01 | 2021-02-02 | 417,443 | — | $0 | 417,443 | SEC↗ |
| EPZM Epizyme, Inc. | A Award | 2021-02-01 | 2021-02-02 | 87,500 | — | $0 | 335,867 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2021-01-25 | 2021-01-27 | 6,069 | $11.41 | $69.2K | 248,367 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2020-06-26 | 2020-06-30 | 4,773 | $16.15 | $77.1K | 250,098 | SEC↗ |
| EPZM Epizyme, Inc. | A Award | 2020-06-25 | 2020-06-30 | 10,500 | — | $0 | 254,871 | SEC↗ |
| EPZM Epizyme, Inc. | M Exercise deriv | 2020-06-18 | 2020-06-22 | 10,000 | — | $0 | 323,333 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2020-06-18 | 2020-06-22 | 10,000 | $22.00 | $220.0K | 244,371 | SEC↗ |
| EPZM Epizyme, Inc. | M Exercise | 2020-06-18 | 2020-06-22 | 10,000 | $8.98 | $89.8K | 264,371 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2020-06-18 | 2020-06-22 | 10,000 | $22.00 | $220.0K | 254,371 | SEC↗ |
| ARDX ARDELYX, INC. | A Award deriv | 2020-06-09 | 2020-06-11 | 23,500 | — | $0 | 23,500 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | D To issuer deriv | 2020-05-06 | 2020-05-06 | 28,000 | — | $0 | 0 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | D To issuer deriv | 2020-05-06 | 2020-05-06 | 18,500 | — | $0 | 0 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2020-03-25 | 2020-03-26 | 3,285 | $15.28 | $50.2K | 254,371 | SEC↗ |
| EPZM Epizyme, Inc. | J Other deriv | 2020-03-24 | 2020-03-26 | 79,167 | — | $0 | 333,333 | SEC↗ |
| EPZM Epizyme, Inc. | A Award deriv | 2020-03-24 | 2020-03-26 | 73,409 | — | $0 | 73,409 | SEC↗ |
| EPZM Epizyme, Inc. | J Other deriv | 2020-03-24 | 2020-03-26 | 2,371 | — | $0 | 333,333 | SEC↗ |
| EPZM Epizyme, Inc. | J Other deriv | 2020-03-24 | 2020-03-26 | 48,727 | — | $0 | 298,737 | SEC↗ |
| EPZM Epizyme, Inc. | A Award | 2020-03-24 | 2020-03-26 | 113,393 | — | $0 | 250,656 | SEC↗ |
| EPZM Epizyme, Inc. | J Other | 2020-03-24 | 2020-03-26 | 56,537 | — | $0 | 80,726 | SEC↗ |
| EPZM Epizyme, Inc. | A Award | 2020-03-24 | 2020-03-26 | 7,000 | — | $0 | 257,656 | SEC↗ |
| EPZM Epizyme, Inc. | A Award deriv | 2020-02-03 | 2020-02-05 | 252,956 | — | $0 | 252,956 | SEC↗ |
| EPZM Epizyme, Inc. | A Award | 2020-02-03 | 2020-02-05 | 52,595 | — | $0 | 137,263 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2020-01-27 | 2020-01-27 | 6,074 | $20.44 | $124.2K | 84,668 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2020-01-24 | 2020-01-27 | 3,002 | $24.62 | $73.9K | 90,742 | SEC↗ |
| EPZM Epizyme, Inc. | A Award | 2020-01-23 | 2020-01-27 | 8,750 | — | $0 | 93,744 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | A Award deriv | 2019-06-25 | 2019-06-27 | 18,500 | — | $0 | 18,500 | SEC↗ |
| ARDX ARDELYX, INC. | A Award deriv | 2019-06-13 | 2019-06-17 | 50,000 | — | $0 | 50,000 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2019-06-13 | 2019-06-14 | 2,074 | $12.10 | $25.1K | 84,994 | SEC↗ |
| EPZM Epizyme, Inc. | A Award | 2019-06-12 | 2019-06-14 | 7,000 | — | $0 | 87,068 | SEC↗ |
| EPZM Epizyme, Inc. | A Award deriv | 2019-01-24 | 2019-01-28 | 347,464 | — | $0 | 347,464 | SEC↗ |
| EPZM Epizyme, Inc. | A Award | 2019-01-24 | 2019-01-28 | 75,383 | — | $0 | 80,068 | SEC↗ |
| NTGN Neon Therapeutics, Inc. | A Award deriv | 2018-11-07 | 2018-11-07 | 28,000 | — | $0 | 28,000 | SEC↗ |
| ARDX ARDELYX, INC. | A Award deriv | 2018-06-13 | 2018-06-15 | 15,000 | — | $0 | 15,000 | SEC↗ |
| EPZM Epizyme, Inc. | A Award deriv | 2018-02-09 | 2018-02-13 | 265,860 | — | $0 | 265,860 | SEC↗ |
| ARDX ARDELYX, INC. | A Award deriv | 2017-06-07 | 2017-06-09 | 15,000 | — | $0 | 15,000 | SEC↗ |
| EPZM Epizyme, Inc. | A Award | 2017-02-28 | 2017-03-02 | 1,708 | $6.21 | $10.6K | 3,070 | SEC↗ |
| EPZM Epizyme, Inc. | A Award deriv | 2017-02-08 | 2017-02-09 | 335,704 | — | $0 | 335,704 | SEC↗ |
| EPZM Epizyme, Inc. | A Award | 2016-08-31 | 2016-09-01 | 1,362 | $6.21 | $8.5K | 1,362 | SEC↗ |
| ARDX ARDELYX, INC. | A Award deriv | 2016-06-02 | 2016-06-06 | 25,000 | — | $0 | 25,000 | SEC↗ |
| EPZM Epizyme, Inc. | A Award deriv | 2016-02-08 | 2016-02-10 | 412,500 | — | $0 | 412,500 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | D To issuer deriv | 2015-06-22 | 2015-06-23 | 50,000 | — | $0 | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | D To issuer | 2015-06-22 | 2015-06-23 | 35,000 | — | $0 | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | A Award | 2015-06-05 | 2015-06-09 | 5,000 | — | $0 | 35,000 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | A Award deriv | 2014-09-23 | 2014-09-25 | 50,000 | — | $0 | 50,000 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | A Award | 2014-09-23 | 2014-09-25 | 30,000 | — | $0 | 30,000 | SEC↗ |